menu search

IMV / IMV to Present at IMMUNOLOGY™ 2022, the AAI Annual Meeting

IMV to Present at IMMUNOLOGY™ 2022, the AAI Annual Meeting
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, today announced the Company will present a poster at IMMUNOLOGY™ 2022, the annual meeting of the American Association of Immunologists (AAI). The meeting will be held May 6-10, 2022, in Portland, Oregon. Presentation Details Proteomic analysis of plasma Read More
Posted: Apr 6 2022, 07:05
Author Name: Business Wire
Views: 102472

IMV News  

IMV Inc. to Announce Fourth Quarter and Fiscal Year 2022 Results and Host a Conference Call and Webcast on March 16, 2023

By Business Wire
March 9, 2023

IMV Inc. to Announce Fourth Quarter and Fiscal Year 2022 Results and Host a Conference Call and Webcast on March 16, 2023

DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $IMV #CancerVaccine--IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company develop more_horizontal

IMV, Inc. (IMV) Q3 2022 Earnings Call Transcript

By Seeking Alpha
November 12, 2022

IMV, Inc. (IMV) Q3 2022 Earnings Call Transcript

IMV, Inc. (NASDAQ:IMV ) Q3 2022 Earnings Conference Call November 11, 2022 8:00 AM ET Company Participants Brittany Davison - Chief Accounting Officer more_horizontal

IMV Inc. to Present at Two Investor Conferences in September

By Business Wire
September 1, 2022

IMV Inc. to Present at Two Investor Conferences in September

DARTMOUTH, Nova Scotia, & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $IMV #DeliveryPlatform--IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage company dev more_horizontal

IMV Inc. to Announce Second Quarter 2022 Results and Host a Conference Call and Webcast on August 11, 2022

By Business Wire
August 4, 2022

IMV Inc. to Announce Second Quarter 2022 Results and Host a Conference Call and Webcast on August 11, 2022

DARTMOUTH, Nova Scotia, & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $IMV #DeliveryPlatform--IMV Inc. (Nasdaq: IMV; TSX: IMV) (“IMV” or “the Company� more_horizontal

IMV to Present at IMMUNOLOGY™ 2022, the AAI Annual Meeting

By Business Wire
April 6, 2022

IMV to Present at IMMUNOLOGY™ 2022, the AAI Annual Meeting

DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immun more_horizontal

IMV Inc. to Present at Two Upcoming Investor Conferences

By Business Wire
April 4, 2022

IMV Inc. to Present at Two Upcoming Investor Conferences

DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immun more_horizontal

IMV Inc. (IMV) CEO Andrew Hall on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 17, 2022

IMV Inc. (IMV) CEO Andrew Hall on Q4 2021 Results - Earnings Call Transcript

IMV Inc. (IMV) CEO Andrew Hall on Q4 2021 Results - Earnings Call Transcript more_horizontal


Search within

Pages Search Results: